The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cardiovascular Effects of the 3 Phosphodiesterase-5 Inhibitors Approved for the Treatment of Erectile Dysfunction
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although reported with vardenafil, prolongation of the QTc interval is not observed with tadalafil (Kloner 2004).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Kloner 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study
Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)34871-1 · Cited by 5,074
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Research works printed but not linked: 50
- 2002, Urology, 60, 1
- 10.1002/j.1939-4640.2002.tb02332.x · DOI · Paper page
- 2001, J Urol, 168, 1322
- 2002, Eur J Med Res, 7, 435
- 10.1016/S0002-9149(98)00916-3 · DOI
- 10.1006/pmed.2000.0643 · DOI · Paper page
- 10.1016/S0022-5347(01)66200-1 · DOI
- 10.1016/j.jacc.2003.07.042 · DOI
- 10.1097/01.ju.0000075055.34506.59 · DOI
- 10.1016/S0002-9149(99)00043-0 · DOI · Paper page
- 10.1016/S0002-9149(99)00046-6 · DOI
- 10.1056/NEJM200006013422201 · DOI · Paper page
- 10.1016/S0002-9343(00)00656-2 · DOI
- 10.1161/circ.104.4.424 · DOI
- 10.1056/NEJM200011023431814 · DOI · Paper page
- 10.1161/circ.104.11.1218 · DOI
- 10.1016/S1520-765X(02)90050-7 · DOI
- 10.1016/S0002-9149(03)00074-2 · DOI · Paper page
- 10.1016/S0735-1097(98)00656-1 · DOI · Paper page
- 10.1016/S0002-9149(00)00896-1 · DOI · Paper page
- 2003, Am J Cardiol, 92, 9M
- 10.1016/S0002-9149(98)00776-0 · DOI
- 10.1016/S0735-1097(00)00705-1 · DOI
- 10.1038/sj.ijir.3900793 · DOI
- 10.1016/j.jacc.2003.09.023 · DOI
- 10.1001/jama.290.23.3129 · DOI
- 10.1097/00004872-200018120-00022 · DOI
- 10.1016/S0895-7061(00)01177-8 · DOI
- 2002, Am J Hypertens, 15, A55
- 2003, J Am Coll Cardiol, 41, 276A
- 2002, Pharmacotherapy, 22, 418.
- 10.1016/S0002-9149(03)00075-4 · DOI
- 2004, Am J Hypertens, 17, 16A.
- Kloner RA Jackson G Emmick JT et al. Interaction between the phosphodiesterase 5 inhibitor tadalafil and the two α-blockers doxazosin and tamsulosin in healthy normotensive men. J Urol . In press.
- 10.1016/S0008-6363(03)00435-8 · DOI
- 10.1016/j.ehj.2003.09.021 · DOI
- 10.1001/jama.287.6.719 · DOI
- 10.1016/S0735-1097(02)02563-9 · DOI
- 2002, Circulation, 106, II-330.
- 10.1016/S0735-1097(02)02139-3 · DOI · Paper page
- 10.1001/jama.1996.03530420033032 · DOI
- 10.1016/S0002-9149(03)01435-8 · DOI
- 10.1038/sj.ijir.3900354 · DOI · Paper page
- 10.1016/S0002-9149(99)00045-4 · DOI
- 10.1016/S0002-9149(02)02342-1 · DOI
- 10.1111/j.1742-1241.2003.tb10566.x · DOI
- 10.1136/bmj.322.7287.651 · DOI
- 2000, Am J Cardiol, 86, 57F
- 2002, Pharmacol Ther, 22, 1371.
- 10.1016/j.amjcard.2003.09.030 · DOI
Cited by
Ban, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
Treatment Options for Erectile Dysfunction
Brant, W. O., Bella, A. J., & Lue, T. F. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.02.001 · Cited by 51
Metadata
- Authors
- Kloner, R. A.
- Affiliations
- From the Heart Institute, Good Samaritan Hospital, and the Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
- Venue
- Circulation
- Published
- 2004-11-09
- Volume
- 110
- Issue
- 19
- Pages
- 3149-3155
- ISSN
- 0009-7322
- 1524-4539
- Cited by
- 153
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
